Tower Research Capital (TRC)’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

Tower Research Capital (TRC)’s Portfolio AYLA Stock Details AYLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-163	Closed	-$2K	–	6865
2021 Q3	$2K	Sell	163 -307	-65%	-$3.68K	﹤0.01%	5364
2021 Q2	$4K	Sell	470 -1,272	-73%	-$13.1K	﹤0.01%	4860
2021 Q1	$19K	Buy	1,742 +570	+49%	+$8.14K	﹤0.01%	3944
2020 Q4	$13K	Buy	+1,172	New	+$13.5K	﹤0.01%	4177
2020 Q3	–	Sell	-3,403	Closed	-$34K	–	5222
2020 Q2	$34K	Buy	+3,403	New	+$47.3K	﹤0.01%	3370

Other funds holding AYLA

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

DAM

DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Tower Research Capital (TRC)'s AYLA Position: Q4 2021 in Review

Tower Research Capital (TRC) sold out of Ayala Pharmaceuticals, Inc. Common Stock (AYLA) in Q4 2021, closing a stake of 163 shares — an estimated $2K sold.

Tower Research Capital (TRC) first reported a position in AYLA in Q2 2020 and held it in 5 quarters. The position peaked at $34K in Q2 2020. 13 funds tracked by Wall St. Rank hold AYLA as of Q4 2021.

Tower Research Capital (TRC) reported no remaining Ayala Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Tower Research Capital (TRC) sold 163 Ayala Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $2K.
Tower Research Capital (TRC) first reported a position in Ayala Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
Tower Research Capital (TRC)'s Ayala Pharmaceuticals, Inc. Common Stock position peaked at $34K in Q2 2020.
13 funds tracked by Wall St. Rank held Ayala Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.